Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Receivables - Other (2022 - 2025)

Updated

Belite Bio (BLTE) recorded Receivables - Other of $700,000 in Q4 2025, up 21.7% from $575,000 a year earlier.

Analysis

Belite Bio (BLTE) Receivables - Other (2022 - 2025) Analysis & Trends

Starting with Q4 2022, Belite Bio's Receivables - Other history includes 6 quarters.

  • Annual Receivables - Other has a three-year compound annual growth rate of 604.7% (FY2022 to FY2025).
  • Across earlier years, Receivables - Other came in at $575,000 in FY2024 (-29.7%), $818,000 in FY2023 and $2,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Belite Bio 6.16 Bn 6.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 700,000.00
Sep 30, 2025 6,000.00
Dec 31, 2024 575,000.00
Sep 30, 2024 18,000.00
Dec 31, 2023 836,000.00
Dec 31, 2022 2,000.00
API Access

Belite Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BLTE&period=max&api_key=YOUR_API_KEY